MDPHP is assumed to act primarily as a powerful norepinephrine-dopamine reuptake inhibitor (NDRI). Decreased re-uptake of norepinephrine and dopamine results in bigger concentrations of the two catecholamine neurotransmitters within the synaptic cleft, or hole concerning neurons. The result of this